LAMP2 and colorectal cancer: LAMP2 is also highly expressed in poorly differentiated human colorectal cancer, prostate cancer, hepatocellular carcinoma, adenoid cystic carcinoma, and lung adenocarcinoma and represents a novel molecular biomarker for these cancer types (13–17).